Integrated within the Roslin Institute, LARIF offers specialised infrastructure and expertise in genome editing and transgenesis across all major farmed animal species. Facilities within the LARIF support transformative research in agriculture, medicine and translation science. This is done through the production, rearing and detailed study of genetically modified large animals. Microinjection as viewed through a microscope Gene-editingOur embryology suite enables targeted modifications at the zygote stage, through advanced micro-injection technology and precise tools such as CRISPR-Cas9.The LARIF provides a fully integrated environment, with:specialised surgical theatresimagingcontainmentenvironmentally controlled animal roomsThis supports the entire process, from implanting engineered embryos through to rearing and breeding of genetically modified populations.This enables:the identification of casual genetic variations linked to heritable traitsthe introduction of beneficial allelesthe removal of harmful allelesthe development of pathogen resistance.The potential of the LARIF in enhancing animal health has been evidenced in the generation of CD163-edited pigs that are resistant to porcine reproductive and respiratory syndrome.WelfareWe are committed to ensuring the highest standards of animal welfare and containment. Our biosecure animal housing maintains safe and controlled conditions that protect both the animals and surrounding environment. This article was published on 2026-05-04